US pharmaceutical tariffs complicate generic drug flows at the US border and Canada entry points
Trump's proposed 200% tariffs on generic pharmaceuticals from 2028 create immediate valuation and origin uncertainty for Canadian importers clearing US-made generics at the US border and Canada custom
Jul 23, 20267 min read0 reactions0 comments